| Literature DB >> 32473197 |
Mark B Slidell1, Jessica J Kandel2, Vivek Prachand3, Fuad M Baroody4, Mohan S Gundeti5, Russell R Reid6, Peter Angelos3, Jeffrey B Matthews3, Grace Z Mak2.
Abstract
BACKGROUND: The COVID-19 pandemic forced surgeons to reconsider concepts of "elective" operations. Perceptions about the time sensitivity and medical necessity of a procedure have taken on greater significance during the pandemic. The evolving ethical and clinical environment requires reappraisal of perioperative factors, such as personal protective equipment conservation; limiting the risk of exposure to COVID-19 for patients, families, and healthcare workers; preservation of hospital beds and ICU resources; and minimizing COVID-19-related perioperative risk to patients. STUDYEntities:
Mesh:
Year: 2020 PMID: 32473197 PMCID: PMC7251404 DOI: 10.1016/j.jamcollsurg.2020.05.015
Source DB: PubMed Journal: J Am Coll Surg ISSN: 1072-7515 Impact factor: 6.113
Procedure-Specific Factors
| Variable | Category | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |
| OR time, min | < 30 | 31–60 | 61–120 | 121–180 | ≥ 181 |
| Anticipated LOS | Outpatient or current inpatient, ready for discharge | 23 h | 24–48 h | ≤ 3 d or current inpatient, nearing discharge | >4 d or current inpatient, unknown LOS |
| Postoperative ICU need, % | Very unlikely | < 5 or current NICU/PICU patient, ready for discharge | 5–10 | 11–25 or current NICU/PICU patient, nearing discharge | ≥ 25 or current NICU/PICU patient, unknown LOS |
| Projected EBL | ≤ 2, or transfusion very unlikely | 3–5, or transfusion | 6–10, or transfusion 50% likely | 11–15, or transfusion | > 15, or multiple transfusions likely |
| Surgical team size, n | 1 | 2 | 3 | 4 | > 4 |
| Intubation needed to perform procedure (probability), % | ≤ 1 | 1–5 | 6–10 | 11–25 | ≥ 25 |
| Surgical site | None of the following row variables | Abdominopelvic MIS | Abdominopelvic open operation, infra-umbilical | Abdominopelvic open operation, supra-umbilical | Other OHNS, upper GI, thoracic |
Procedure score 7 to 35. Higher scores associated with potentially worse outcomes, increased risk to provider, and/or increased hospital resource use.
GI, gastrointestinal; LOS, length of stay; MIS, minimally invasive surgery; NICU, neonatal ICU; OHNS, otolaryngology-head and neck surgery; OR, operating room; PICU, pediatric ICU.
A weight-based estimated blood loss calculator available at: https://reference.medscape.com/calculator/estimated-blood-volume.
Surgical sites that would fall into category 1 include orthopaedic and neurosurgical cases, as well as head and neck or axillary lymph node biopsies. If the approach also includes one of the other surgical sites, and then the higher scoring site would take precedence in scoring.
Disease-Specific Factors
| Variable | Category | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |
| Nonoperative treatment option effectiveness | None available | Available, | Available, 40% to < 60% as effective as operation | Available, 60% to < 95% as effective as operation | Available, ≥ 95% or equally effective |
| Nonoperative treatment option resource use/exposure risk | Significantly worse/not applicable | Somewhat worse | Equivalent | Somewhat better | Significantly Better |
| Impact of 2-wk delay in disease outcomes | Significantly worse | Worse | Moderately worse | Slightly worse | No worse |
| Impact of 2-wk delay in surgical difficulty/risk | Significantly worse | Worse | Moderately worse | Slightly worse | No worse |
| Impact of 6-wk delay in disease outcomes | Significantly worse | Worse | Moderately worse | Slightly worse | No worse |
| Impact of 6-wk delay in surgical difficulty/risk | Significantly worse | Worse | Moderately worse | Slightly worse | No worse |
Disease score 6 to 30. Higher score equates with less harm to patient if nonoperative treatment is pursued and/or operation delayed. Limited resources might be better deployed for diseases where nonoperative treatment is less effective or not available, or delayed surgical treatment leads to worse disease outcomes and/or increases surgical risk. Consideration of disease factors at 2 different time points integrates natural history of disease, significance of patient symptoms, and time sensitivity of operation into the decision-making process.
Patients scoring 1 point under “nonoperative treatment option effectiveness” will also score 1 point under “nonoperative treatment option resource use/exposure risk” because the question would be “not applicable.”
Patient-Specific Factors
| Variable | Category | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |
| Child's age | 12 y to 20 y | 5 y to younger than 12 y | 6 mo to younger than 5 y | Full term, or preterm infant | Preterm infant < 50 wk post conception |
| Pediatric chronic lung disease, or cystic fibrosis, or pHTN | None | Mild BPD or asthma (no supplemental O2 required after 36 wk), or history of pHTN (resolved) | Intermittent bronchodilators, inhaled steroids, or mild to moderate pHTN (no current medications but needed for procedures) | Daily diuretics, bronchodilators, inhaled steroids, or moderate pHTN (single medication) | On supplemental O2 or history of respiratory hospitalizations or single lung or severe pHTN (multiple current medications) |
| OSA/difficult airway, AHI | No OSA or earlier intubation without airway concern | Mild OSA (AHI 1–5) | BMI < 15 kg/m2 | BMI ≥ 25 kg/m2 | On CPAP or greater support, or ASA ≥ 3, or known difficult airway (AHI > 20) |
| Pediatric congenital heart disease | None | Minor (eg PFO or PDA) or repaired Moderate defect | Moderate (eg ASD, VSD) or repaired major defect | Major (eg transposition great vessels, pulmonic stenosis) or repaired severe defect | Severe (eg hypoplastic left heart, single ventricle) |
| Diabetes | None | — | Mild (no medications) | Moderate (po meds only) | More than moderate (insulin) |
| Immunocompromised | No | — | Mild (pregnancy, single immunosuppressive medication) | Moderate (multiple immunosuppressive meds, chronic steroids) | Severe (malignancy, transplantation, recent chemotherapy) |
| ILI or COVID-19 symptoms (fever, cough, sore throat, body aches, diarrhea, etc) | None (asymptomatic) | — | — | — | Yes |
| Exposure to known COVID-positive patient (past 14 d) | No | Probably not | Possibly | Probably | Yes |
Patient score 8 to 40. Total combined score = procedure + disease + patient. Higher score is associated with potentially worse outcomes, increased risk to providers, and/or increased hospital resource use.
AHI, apnea hypopnea index; ASA, American Society of Anesthesiologists; ASD, atrial septal defect; BPD, bronchopulmonary dysplasia; ILI, influenza-like illness; OSA, obstructive sleep apnea; PDA, patent ductus arteriosus; PFO, patent foramen ovale; pHTN, pulmonary hypertension; VSD, ventricular septal defect.
Hematologic malignancy, stem cell transplantation, solid organ transplantation, active cytotoxic chemotherapy, anti-tumor necrosis factor-α, immunosuppressants, steroid use, congenital immunodeficiency, hypogammaglobulinemia on IV immunoglobulin, HIV with CD4 < 200 cells/mm3.
Figure 1Number of completed vs deferred cases by pediatric medically necessary, time-sensitive (pMeNTS) score. The pMeNTS scoring system was applied to all 101 completed and deferred procedures during the initial restrictions on elective operations at Comer Children's Hospital, The University of Chicago Medicine from March 23 through April 19, 2020. The y-axis represents the number of cases with a specific pMeNTS score. The arrows with dotted lines represent the upper and lower threshold pMeNTS scores that were allowed to proceed or that were deferred during this period. The threshold can be dynamically adjusted to respond to changes in operating room capacity, resource availability, and risk tolerance of the individual institution. This facilitates preservation of operating room capacity for trauma, emergency, and highly urgent cases.